Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 140 of 200 Β· By data quality, then INN

  1. vernakalant hydrochloride

    BRINAVESS

    EMA: approved

    C01BG11
  2. vildagliptin

    GALVUS Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved

    A10BH02
  3. vilobelimab

    GOHIBIC

    EMA: approved

    L04AJ10
  4. vinflunine

    JAVLOR

    EMA: approved

    L01CA05
  5. volanesorsen

    WAYLIVRA

    EMA: approved

    C10AX18
  6. vonicog alfa

    VEYVONDI

    EMA: approved

    B02BD10
  7. vorapaxar

    ZONTIVITY

    EMA: withdrawn

    B01
  8. voretigene neparvovec

    LUXTURNA

    EMA: approved

    S01XA27
  9. vosaroxin

    QINPREZO

    EMA: application withdrawn

    L01
  10. votumumab

    HUMASPECT

    EMA: withdrawn

    V09IX
  11. vysribli

    VYSRIBLI (PREVIOUSLY DENOSUMAB INTAS)

    EMA: approved

    M05BX04
  12. ximelagatran

    XIMELAGATRAN 36 MG FILM COATED TABLETS

    EMA: application withdrawn

  13. yttrium [90y] chloride

    YTTRIGA

    EMA: approved

    V09
  14. zapomeran

    KOSTAIVE

    EMA: approved

    J07BN01
  15. ziconotide

    PRIALT

    EMA: approved

    N02BG08
  16. zilucoplan

    ZILBRYSQ

    EMA: approved Β· TGA: approved

    L04AJ06
  17. zinc

    NULL

    EMA: approved Β· TGA: approved

    A16AX05
  18. zolbetuximab

    VYLOY

    EMA: approved Β· PMDA: approved

    L01FX31
  19. zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    AFLUNOV

    EMA: approved

    J07BB02
  20. zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    CELLDEMIC

    EMA: approved

    J07BB02
  21. zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)

    ZOONOTIC INFLUENZA VACCINE SEQIRUS

    EMA: approved

    J07BB02
  22. abacavir + lamivudine

    ABACAVIR/LAMIVUDINE VIATRIS Alphapharm Pty Ltd

    TGA: approved

  23. abacavir, dolutegravir, lamivudine

    ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE

    FDA: approved

  24. acamprosate

    CAMPRAL Alphapharm Pty Ltd

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.